Intrarenal renin-angiotensin system mediates fatty acid-induced ER stress in the kidney.
patients suffering from DN (43) . In proteinuric kidney disease, FFAs bounding to albumin are filtered and reabsorbed by the proximal tubule, which may contribute to tubulointerstitial inflammation and fibrosis (49, 50) . Accumulation of saturated FFA and their metabolites within cells produces lipotoxicity resulting in significant cellular dysfunction and injury (58) . It is now widely accepted that lipid accumulation in the kidney critically contributes to the pathogenesis of DN.
The endoplasmic reticulum (ER) is the organelle where transmembrane, secretory, and ER resident proteins are folded and matured (2, 51) . Accumulation of unfolded or misfolded protein results in ER stress and activates the unfolded protein response (UPR). In mammalian cells, there are three major UPR pathways, activated by transmembrane sensors located in the ER membrane. These three major pathways are the inositol requiring protein 1 (IRE1), activating transcription factor 6 (ATF6), and the protein kinase-like ER kinase (PERK)-mediated response (64) . ER-resident chaperones, including the 78-kDa glucose regulated protein [GRP78, also known as binding immunoglobulin protein (BiP)], assist in folding newly synthesized proteins, prevent the accumulation of misfolded proteins, and enhance ERassociated protein degradation (31, 59) . However, prolonged or severe ER stress activates PERK-mediated phosphorylation of eukaryotic initiation factor (eIF2␣), which leads to expression of activating transcription factor 4 (ATF4) and the transcription factor C/EBP homologous protein (CHOP) [also known as growth arrest and DNA damage (GADD)], leading to cell death via apoptosis (42) .
ER stress could be induced in podocytes in vitro and in a rodent model by protein accumulation (15) or by exposure of renal proximal tubular cells to high albumin concentrations resulting in apoptosis (37) . It has been shown that during initial ER stress the tubular epithelial cells can undergo adaptive and protective response, but the persistent proteinuria and hyperglycemia can lead to an epithelial apoptosis (28) , followed by an inflammatory response and fibrosis.
It is well known that angiotensin II (ANG II) plays the most crucial roles in DN through activating angiotensin type 1 receptors. The angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) are widely used to delay the progression of DN. We (55) and others (23, 46) have demonstrated that renin-angiotensin system (RAS) blockade with ACEi, ARB, or renin inhibitor effectively attenuated ER stress in kidneys of streptozotocin (STZ)-induced type 1 diabetic animals, suggesting ANG II as a regulator of ER stress and apoptosis in diabetic kidneys.
Type 2 diabetes is usually associated with obesity and excessive tissue lipid accumulation. Palmitic acid (PA), a dietary saturated FFA and the most abundant circulating fatty acid in vivo (41) , induces ER stress (10, 32, 44, 57) and is a proapoptotic factor in podocytes, proximal tubule cells, and mesangial cells (20, 26, 34, 44) . However, the intracellular pathways involved in the development of fatty acidmediated ER stress within the kidney are not fully understood.
The objectives of the present study were to investigate whether the activation of local RAS directly mediated ER stress induced by PA in human HK2 cells and whether the treatment with valsartan, an AT 1 R blocker, inhibited renal ER stress in mice fed with a high-fat diet.
MATERIALS AND METHODS
Materials. PA, fatty acid-free bovine serum albumin (BSA), tunicamycin, and MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-dipthenyltetrazolium bromide) were purchased from Sigma-Aldrich; anti-BiP (3177), anti-CHOP (2895), anti-peIF2␣ (3597)/eIF2␣ (9722), anti-IRE1␣ (3294), and anti-activated caspase-3 (9664) antibodies from Cell Signaling; anti-GRP78 (BiP) (SC-13968 for immunohistochemistry) from Santa-Cruz Biotechnology; anti-ATF4 from Abcam (ab50546); and anti-␤-actin from Sigma. Renin was obtained from Cayman Chemical, and ANG II was purchased from Sigma-Aldrich. The horseradish peroxidase-conjugated secondary antibodies were obtained from Dako. Valsartan and aliskiren were kindly provided by Novartis (Basel, Switzerland).
PA preparation. PA was prepared as described previously (20, 27) . Briefly, a stock solution of sodium palmitate (5 M) was conjugated to fatty-acid-free BSA at 37°C for 1 h before addition cultured cells. The PA concentration used in this study was 0.8 mM complexed to BSA (0.2%), which is within the reported nutritional and metabolic disorders ranges of 720 to 3,730 mol/l (25). BSA with vehicle (see below) used for control experiments was prepared and handled exactly the same as BSA to which PA was conjugated to.
Cell culture and treatment. The immortalized human proximal tubular cell line HK2 was obtained from ATCC and grown in 100-mm culture dishes (Corning, Corning, NY). The cells were cultured in DMEM containing glutamax (Gibco/Invitrogen, Burlington, ON, Canada), supplemented with 10% FCS, 100 units/ml penicillin, and 100 g/ml STZ in an atmosphere of 5% CO 2 in air at 37°up to ϳ90% confluence. All experiments were performed after overnight cell starvation by addition of culture medium without FCS. Cells were either fixed in 4% paraformaldehyde for immunofluorescence or lysed with RIPA buffer (25 mM Tris·HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, and 0.1% SDS; Thermo Scientific) plus a protease inhibitor cocktail for Western blotting. HK2 cells were pretreated for 1 h with valsartan (10 Ϫ6 M) or aliskiren (10 Ϫ7 M) (stock solution was prepared in DMSO) followed by treatment with PA (0.8 mM) or tunicamycin (2 g/ml) for 24 h. HK2 cells treated with vehicle (DMSO) and BSA were used for control. For the ANG II study, HK2 cells were treated with ANG II (10 Ϫ7 M) or renin (10 Ϫ8 M) for 24 h. Cell viability assay. The MTT assay was performed to examine the effect of PA on cell viability. Briefly, HK2 cells were seeded into a 96-well culture plate at a density of 8,000 cells/well. After 24-h incubation, the cells were treated with PA at concentrations ranging from 0, 0.1, 0.2, 0.4, 0.8, and 1.2 mM for a further 24 h. Cell viability was determined by the reduction of MTT. The absorbance was measured by using a Geniosplus microplate reader (Genius-basic, Tecan, Austria) at wavelengths of 560 nm (MTT formazan) and 670 nm (background). The experiment was conducted in triplicate. The results of the experiments are expressed as percentage of viable cells that was observed in PA-treated cells.
In situ cell death detection (terminal deoxynucleotidyl transferasemediated deoxyuridintriphosphate nick end labeling assay). Apoptotic cell death was detected by terminal deoxynucleotidyl transferasemediated deoxyuridintriphosphate nick end labeling (TUNEL) assay, using an DeadEnd Colorimetric TUNEL System Kit (cat no. 7130; Promega, Madison, WI) according to the manufacturer' instructions. Brown-labeled TUNEL-positive cells were counted under a ϫ400 magnification in at least 10 random fields. The apoptotic index was calculated as the percentage of TUNEL-positive cells/total number of HK2 cells. All counting procedures were performed in a blinded fashion.
Measurement of ANG II. Blood and urine samples as well as culture medium were collected and ANG II concentrations were determined using commercially available Iodine [
125 I]ANG II radioimmunoassay kit (cat no. D02PJB; Beijing North Institute of Biological Technology, Beijing, China) following the manufacturer's protocol. The assay is based on the competition of 125 I-ANG II and ANG II (standard or samples) binding to the limited quantity of antibodies specific for ANG II in each reaction mixture. The standard range of the kit is 25-800 pg/ml, and the sensitivity is 10 pg/ml. The concentration of ANG II was extrapolated from the standard curve constructed in the same plate using curve-fitting software capable of four parameter logistics.
Animals and treatments. Eight-week-old male C57BL/6 mice were obtained from the Experimental Animal Center of Sun Yat-Sen University in Guangzhou, China. All mice were housed in an animal facility with a 12-h light-dark cycle and water ad libitum. The mice were fed with a low-fat diet (10% of total calories from fat) or a high-fat diet (60% of total calories from fat; Guangdong Medical Lab Animal Center, China) for 14 wk. The diets are otherwise identical in their protein, mineral, and ion content. The mice were assigned to three groups, control with standard diet (CTL), high-fat diet group (HFD), and high-fat diet with valsartan treatment (HFDV; 8 mg/kg per day). Valsartan was administered in drinking water for 10 wk. Mice were placed in metabolic cages for 24-h urine collection at week 14, and the body weight and the blood glucose were measured at these time points. On week 14, all mice were anesthetized with pentobarbital, and the kidneys were rapidly excised from mice to perform biochemical and histological examinations, as described in following sections. All animal procedures were in accordance with the policies of the Animal Care and Use Committee, Sun Yat-Sen University, and conformed to the Guide for the Care and Use of Laboratory Animals of the National Institute of Health in China.
Blood and urine chemistry. The blood concentration of glucose was measured by blood glucose meter (Bayer Healthcare), and creatinine level was measured by using QuantiChrom Creatinine Assay Kit (Bioassay Systems). Urinary kidney injury molecule 1 (KIM-1) levels were measured by using CLIA Kit (Cloud-Clone, Houston, TX). The urinary protein was measured by using the BCA Protein Assay Kit (Thermo Scientific). Urinary protein excretion rate (UPER) was calculated by the following formula: 24-h total volume of urine (ml/100 g body wt) ϫ urinary protein levels (g/ml) (39) .
RNA extraction and quantitative real-time PCR. Total RNA was extracted from the kidney cortex or cultured cells according to the manufacturer's instructions for Trizol reagent (Invitrogen). Total RNA (1,000 ng) was used for reverse transcription using PrimeScript RT Reagent Kit Perfect Real Time Kit (Takara Bio). The cDNA was used for quantitative real-time PCR analysis (qPCR) using SYBR Premix Ex Taq (Perfect Real Time) (Takara Bio). All samples were analyzed in triplicate. Average cycle threshold values in each group are shown in Table 1 . The calibrator sample was selected from PBS-treated tissue or cell samples, and GAPDH was used as an internal control. Relative amounts of mRNA were normalized by GAPDH and a control sample and calculated by using the comparative Ct (2Ϫ⌬⌬Ct) (cycle threshold) method. Signals from the control group were assigned a relative value of 1.0. Primers were designed based on previous publications or on the primerbank. Primer sequences used are provided in Tables 2 and 3 .
Western blotting. Cell protein was extracted with RIPA buffer supplemented with protein inhibitor cocktail. Protein lysate was prepared from the kidney cortex as described previously (55) . The total protein concentrations of the samples were measured by the BCA method. Equal amounts of protein samples were subjected to SDS-PAGE, and they were then transferred to PVDF membranes. After being blocked with 5% fat-free milk powder in 0.1% Tween 20 in Tris-buffered saline (20 mmol/l Tris·HCl and 150 mmol/l NaCl, pH 7.4), the blots were incubated with primary antibodies. Corresponding secondary antibodies were visualized using enhanced chemiluminescence (Pierce, Bradford, IL). Signals were quantified by densitometry and normalized by corresponding value of ␤-actin and control samples.
Immunohistochemistry and immunofluorescence. Sections (4-m thick) cut from 4% paraformalin-fixed, paraffin-embedded kidney samples were used for hematoxylin and eosin staining and immunostaining of BiP (55) . Briefly, after samples were dewaxed and rehydrated, a microwave pretreatment in citrate buffer (pH 6.0) was performed to unmask antigens present in the renal tissue. Tissue sections were then incubated overnight at 4°C with BiP antibodies.
After being rinsed in phosphate-buffered saline, slides were exposed for 1 h to the secondary antibody. Kidney sections were finally incubated with ABC complex (Vector Laboratories, Burlingame, CA) for 30 min, and bound peroxidase activity was detected with the 3,30-diaminobenzidine kit. Samples were imaged with a light microscope (Leica DM 2000).
HK2 cells were seeded onto sterile glass coverslips in six-well dishes. The following days, cells were treated as indicated above. Cells were fixed with 1 ml 4% paraformaldehyde in PBS for 20 min before permeabilization in 0.25% Triton X-100 in PBS for 15 min at room temperature with gentle agitation. Cells were blocked with 10% normal goat serum for 30 min followed by incubation with primary (4°C, overnight) and secondary (1 h, at room temperature) antibodies. Primary antibodies were detected with fluorescently labeled antimouse Alexa 488 and anti-rabbit Alexa 594 diluted 1:200 (Invitrogen). Nuclei were counterstained with DAPI (1 mg/ml in PBS), and coverslips were mounted onto slides and visualized with a confocal fluorescent microscope (Leica DMI4000B). Quantifications were performed in a blinded manner. ImageJ software was used to quantify the BiP or CHOP immunofluorescence intensity by measuring the positive staining area.
Statistical analysis. Results are presented as the means Ϯ SD. Data were analyzed by one-way ANOVA and Student-Newman-Keuls tests for multiple comparisons. Statistical significance was accepted at the P Ͻ 0.05 level.
RESULTS
Cell viability after PA treatment. As a vehicle BSA treatment alone did not induce increases in protein abundance of ER stress markers BiP and CHOP in HK2 cells, and valsartan or aliskiren had no effects on these markers (Fig. 1, A and B) . To investigate HK2 cell viability in response to PA treatment, MTT assay (uptake directly correlates with the number of viable cells) was employed. As shown in Fig. 1C , there was a dose-dependent decrease in cell viability after PA treatment when compared with nontreatment (Fig. 1C) . The concentration of 0.8 mM was chosen for further experiments.
Valsartan or aliskiren blocks PA-induced ER stress in HK2 cells. PA produced a significant increase in the expression of markers of ER stress by Western blotting. Specifically, incu- 
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bation of HK2 cells with 0.8 mM PA produced significantly increased levels of BiP, IRE1␣, p-eIF2␣, and ATF4 proteins after 24 h (Fig. 1, D and E) , whereas eIF2␣ protein abundance was unchanged. The proapoptotic transcription factor CHOP, which is typically upregulated during severe ER stress, was detectable at low levels in controls and was increased ninefold after incubation of PA (Fig. 1, D and E) . Valsartan or aliskiren treatment significantly decreased expression of BiP, IRE1␣, Valsartan or aliskiren prevents HK2 cell apoptosis induced by PA. To investigate whether PA induced HK2 cell apoptosis, we examined the activation of an effector caspase-3 by immunoblotting using an antibody specific for cleaved and activated caspase-3. Incubation with PA increased cleaved caspase-3 protein abundance, indicating that PA induced HK2 cell apoptosis. This was significantly prevented by either valsartan or aliskiren treatment (Fig. 3, A and B) . The percentage of HK2 cells containing TUNEL-positive nuclei significantly increased in response to PA treatment, which was attenuated by valsartan or aliskiren (Fig. 3, C and D) .
ANG II is involved in PA-induced ER stress in HK2 cells. Since RAS blockade with valsartan or aliskiren attenuated ER stress, ANG II was therefore considered to play a role in PAinduced ER stress in HK2 cells. Accordingly, we measured ANG II content in medium of cultured HK2 cells. As shown in Fig. 3E , levels of ANG II was significantly higher in all PA-treated groups than controls. ANG II level showed about 22% decrease in aliskiren treated cells (44.89 Ϯ 1.78 pg/ml) compared with PAtreated cells (58.65 Ϯ 5.93 pg/ml), although this decrease did not reach statistical significance (P ϭ 0.06).
To further investigate the role of RAS in ER stress, we examined whether exposure to renin (10 Ϫ8 M) or ANG II (10 Ϫ7 M) directly caused ER stress in HK2 cells. As seen in Fig. 3 , G and H, ANG II treatment was associated with strong upregulation of BiP in HK2 cells; CHOP expression was also significantly increased. In contrast, neither BiP nor CHOP protein expression was changed in response to renin treatment.
Effects of valsartan or aliskiren on mRNA levels of RAS components in HK2 cells treated with PA.
The mRNA expression of angiotensinogen, renin, and AT 1 R was significantly increased in all PA-treated cells; single treatment with valsartan or aliskiren had no effect on such an increase. ACE mRNA levels were reduced in PA-treated HK2 cells, whereas valsartan or aliskiren treatment was associated with recovery of ACE mRNA expression (Fig. 3F) .
Valsartan or aliskiren does not block tunicamycin-induced ER stress in HK2 cells. To test whether RAS was universally involved in ER stress, we examined the effect of RAS inhibition on ER stress induced by other inducers, such as tunicamycin (2 g/ml). Consistent with previous studies, incubation of HK2 cells with tunicamycin for 24 h produced increases in BiP, CHOP, IRE1␣, p-eIF2␣, and ATF4. However, neither valsartan nor aliskiren was able to reduce these ER stress marker expressions, indicating that RAS activation is unlikely involved in tunicamycin-induced ER stress in HK2 cells (Fig. 4) .
Valsartan prevents tubular injury in the kidneys of mice fed with high-fat diet. Metabolic data of mice fed a normal, standard chow (CTL) or high-fat diet with (HFDV) or without (HFD) valsartan treatment are shown in Table 4 . The body weight and kidney weight in mice fed with high-fat diet were significantly higher than that of CTL mice. The level of plasma glucose was significantly higher in high-fat-diet mice with (7.96 Ϯ 0.43 in HFDV vs. 6.74 Ϯ 0.21 mmol/l in CTL, P Ͻ 0.05) or without valsartan (7.49 Ϯ 0.18 mmol/l, P Ͻ 0.05 when compared with CTL) than control mice. Urine protein excretion rate was higher in high-fat-diet mice (47 Ϯ 4.3 in HFD vs. 31 Ϯ 3.8 g/100 g body wt in CTL, P Ͻ 0.05) than controls, and valsartan treatment slightly improved urinary protein excretion (35 Ϯ 4.5 g/100 g body wt in HFDV). mRNA levels of two tubular injury markers were examined in the cortex of kidneys. Renal mRNA expression levels of neutrophil gelatinase-associated lipocalin (NGAL) and KIM-1 were significantly increased in mice with high-fat diet, valsartan treatment was associated with reduced mRNA expression of KIM-1 compared with high-fat-diet mice. Urinary KIM-1 levels was increased in mice with high-fat diet but decreased after valsartan treatment (Fig. 5, A and B) .
Serum and urine ANG II levels are increased in mice fed with high-fat diet. To examine whether high-fat diet was associated with renal RAS activation, ANG II levels were therefore examined. Serum ANG II concentration was significantly increased in mice fed with high-fat diet when compared with controls, and valsartan treatment induced even higher level than that in nontreated mice (Fig. 6A) . Compared with controls, urine ANG II levels showed significant increases in mice fed with high-fat diet, and valsartan treatment was asso- ciated with a higher level than nontreated mice, but it did not reach statistical significance (Fig. 6B) .
Effects of valsartan on mRNA levels of RAS components in mice fed with high-fat diet. The renal mRNA expression of angiotensinogen was not different among three groups; however, renin mRNA expression was dramatically increased in mice fed with high-fat diet and this increase was greater after valsartan treatment. The renin receptor mRNA level was decreased and ACE mRNA expression was increased in high-fat-diet mice. Valsartan treatment was associated with increased mRNA level of ACE and AT 1 R when compared with controls (Fig. 6C) . Valsartan reduces BiP and CHOP expression in the kidneys of mice fed with high-fat diet. As shown in Fig. 7 , Western blotting demonstrated significantly increased expression of BiP and CHOP proteins in the cortex of mice with high-fat diet compared with controls and valsartan treatment prevented such an increase (Fig. 7, A and B) . mRNA levels of BiP did not change in mice with high fat, whereas CHOP mRNA levels was significantly increased in high-fat-diet mice and almost fully returned to control levels in response to valsartan treatment.
An overall increase in vacuolated tubular cells was detected in the cortex of the HFD mice (Fig. 8B) . The vacuoles were as large as the nucleus or some vacuoles were even larger and some proximal tubular cells appeared to be completely filled with these vacuoles. Chronic valsartan treatment largely suppressed the development of vacuolated tubular cells (Fig. 8C) .
BiP protein was mainly observed in the cytoplasm of renal proximal tubular cells, with occasional glomerular staining in both control and high-fat diet fed mice. Importantly, labeling of BiP in high-fat-diet mice (Fig. 8, E and H) was more extensive than that in control mice, which was partially attenuated by valsartan treatment (Fig. 8, F and I) .
DISCUSSION
In the present study, we found that RAS activation is involved in saturated fatty acid PA-induced ER stress and apoptosis in HK2 cells. AT 1 R blocker valsartan significantly attenuated obesity-associated ER stress in proximal tubule cells in the kidney of mice fed with high-fat diet.
During UPR, PERK phosphorylation activates eIF2␣, which reduces ER stress by reducing the load on the ER through inhibiting translation of new proteins from mRNA via PERKeIF2␣-ATF4 pathway, leading to a reduction in overall protein synthesis (11, 64) . IRE1 mediates a frame shift of XBP1 mRNA in the coding sequence, leading to the manufacture of the potent transcriptional activator XBP1s, which activates genes encoding ER chaperones, promoting protein folding, maturation, and secretion in an attempt to decrease ER load and relieve ER stress (9, 13, 64) .
ER stress has been proposed to propagate development of DN. A number of studies have documented activation of the ER stress in cultured cells, diabetic animal kidneys, and kidney biopsy samples of patients with diabetes (12, 23, 30, 35, 46, 48, 55) . In humans, increased levels of XBP1 and ER chaperones are shown in patients with established DN when compared with those with mild diabetes (28) . In STZ-treated rats, increased expression of BiP and CHOP in glomerular and tubular cells was observed (30) . Additionally, high glucose or fatty acid has been reported to induce ER stress in human mesangial cells (40) , podocytes, and tubular cells (27) . Aberrant metabolic conditions such as hyperlipidemia in obese individuals promoting an environment of systemic ER stress could synergistically contribute to the pathophysiology of both insulin resistance and hyperglycemia in obesity and T2D.
PA is the predominant circulating saturated FFA. PA induces insulin resistance in human podocytes (25) and causes proximal tubular and tubulointerstitial damage (43) , indicating its deleterious role in the development of DN. PA has been demonstrated to induce ER stress in the proximal tubular cells (20, 21, 27, 48) . The ability of PA to increase ER stress in HK2 cells was confirmed in this study via measurement of increased ER stress makers, such as BiP, IRE1␣, p-eIF2␣, ATF4, and CHOP. Our data showed that both PERK and IRE1 pathways inducing ER stress were activated by PA in proximal tubule cells. Importantly, we for the first time demonstrated that ER stress induced by PA in renal proximal tubular cells can be significantly reduced by the AT 1 R blocker valsartan or renin inhibitor aliskiren, suggesting an involvement of local RAS in maintaining homeostasis of kidney cells during metabolic alterations such as increased fatty acid overload. In HK2 cells, increased mRNA levels of angiotensinogen and renin as well as ANG II secretion were observed after PA treatment, providing evidence for activation of local RAS by lipids overloading. We therefore treated HK2 cells with exogenous ANG II or renin to examine their direct effect on ER stress. ANG II clearly induced an increase of BiP and CHOP in HK2 cells, but renin did not. These data suggested that saturated fatty acid PA induces ER stress and apoptosis in proximal tubule cells, at least partly, by activating local RAS that releases ANG II via yet to be determined intracellular pathways. It is noted that aliskiren, at current concentration, induced a reduction of ANG II secretion from HK2 cells treated with PA, although such a reduction was not statistically significant (P ϭ 0.06). Nevertheless, aliskiren indeed prevented ER stress which is likely induced by increased ANG II in cultured HK2 cells in response to PA treatment.
Involvement of ANG II in obesity-associated ER stress in the kidneys was also supported by our in vivo studies. Upregulation of both BiP and CHOP was observed in the kidney cortex from the mice fed with high-fat diet, which was significantly attenuated by valsartan treatment. In particular, increased urine ANG II level, together with elevated mRNA levels of renin and ACE in the kidney of the mice fed with high-fat diet, indicates a lipid-induced activation of intrarenal RAS. Consistent with previous studies (5, 6, 16, 22) , we also found accumulation of lipid vacuoles in the proximal tubules and impairment of tubular structure, a prominent feature of high-fat diet-induced kidney disease. Several studies highlighted an increase of neutral lipid in the kidney after a high-fat diet (17, 48 -50, 56) . A recent study (5) , however, demonstrated that the majority of vacuoles are phospholipids and Values are means Ϯ SE. HFD, mice fed with high-fat diet; HFDV, mice fed with high-fat diet and valsartan; BW, body weight; KW, kidney weight; S-Cr, serum creatinine; BG, blood glucose; UO, urine output; UPER, urinary protein excretion rate. *P Ͻ 0.05, compared with control; †P Ͻ 0.05, compared with HFD; n ϭ 6 in each group. cholesteryl esters. The observed impairment of tubular morphology in high-fat diet fed mice was associated with increased kidney and urine KIM-1 levels, a transmembrane protein expressed in proximal renal tubular epithelial cells in damaged regions and a sensitive biomarker for the detection of early stage of nephropathy in T2D animals and patients (1, 14) . Interestingly valsartan treatment showed a preventive effect in decreasing KIM-1. Therefore, the finding that valsartan treatment improved tubular morphology and attenuated ER stress in the proximal tubule supported a role of local RAS in lipid overload induced structural and functional impairment in the kidneys after high-fat diet.
Recently the presence of local organ-specific RAS has been demonstrated in kidney, heart, aorta, and several other organs. Their activation lead to structural and functional changes, which are independent of those elicited by the classical renin- angiotensin endocrine system (4). Components of these local RAS have been found in cells and tissues, and some of their local functions play an important role in cellular homeostasis (4, 65) . Local intracrine/intracellular ANG II is profoundly involved in cell proliferation, oxidative stress, nitric oxide production, and energy metabolism in the proximal tubules, as reviewed by Ref. 65 . In addition, local RAS in adipocytes is activated during obesity in humans and obesity-prone rats show increased levels of ANG II and hypertension (61) . Adipocyte-specific deficiency of angiotensinogen prevented the obesity-induced increase in plasma levels of ANG II (61) . These studies likely indicate a potential role of fatty acid in activation of local RAS, as seen in the present study. ANG II has been shown to contribute to the induction of ER stress and ER stress-associated apoptosis in the hearts of diabetic mice (60) . Treatment of adult rat cardiac myocytes with ANG II induced cardiac myocyte apoptosis along with the inductions of ER chaperones and CHOP, either of which was inhibited by AT 1 R blockers (38) . ARB (23) or renin inhibitor treatment (55) significantly attenuated the ER stress markers and ER stress-induced apoptosis in STZ-induced diabetic kidneys, although detailed sites where ER stress occurred were not specified. It is therefore reasonable to assume that ANG II may mediate PA-induced ER stress and apoptosis in kidney cells. Another interesting outcome of the current study was the finding that RAS blockade with valsartan or aliskiren was not able to prevent the ER stress induced by tunicamycin, a typical chemical inducer, indicating that RAS activation is unique and specific in PA-induced ER stress in the proximal tubule cells. Tunicamycin causes ER stress likely by specifically inhibiting NH 2 -linked glycosylation of peptides in ER (36, 45) . The mechanism by which RAS blockade failed to prevent tunicamycin-induced ER stress is yet unknown.
Emerging evidence suggest an association between ER stress and DN, two characteristics of which are fibrosis and inflammation. Recent data demonstrate that lipid accumulation occurs in the kidney after a high-fat caloric exposure, leading to impairment of tubular cell structure and associated inflammation and fibrosis (5), as increased gene expression of profibrotic and proinflammatory molecules were observed in the kidneys of high-fat diet (17, 56) . ER stress facilitates fibrotic remodeling through activating proapoptotic pathways and in- ducing epithelial-mesenchymal transition (47) . Prolonged ER stress may lead to fibrosis through the activation of CHOPmediated apoptosis followed by the release of profibrotic cytokines (24) , such as release of transforming growth factor-␣ and expression of collagen I (19) . ER stress is also able to induce inflammatory responses through the activation of NF-B and MAPK/JNK pathways (62) and NLRP3 inflammasome (33) , which regulates the maturation and secretion of proinflammatory cytokines IL-1␤ and IL-18 (8) .
In summary, our present data demonstrate that local RAS activation mediates FA-induced ER stress and FA-associated impairment of the proximal tubular cells. These findings contribute to the understanding of the cellular mechanisms underlying the development of chronic kidney disease caused by saturated fatty acids with interactions between ER and RAS.
